Article metrics

Download PDFPDF

363 Vactosertib and durvalumab as second or later line treatment for PD-L1 positive non-small cell lung cancer: interim result

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020317037
Dec 202058022
Jan 20214506
Feb 202144013
Mar 20214608
Apr 20212205
May 202113010
Jun 2021008
Jul 20210012
Aug 20210013
Sep 2021005
Oct 202164040
Nov 202170022
Dec 20213407
Jan 20222609
Feb 20222806
Mar 202237017
Apr 202260018
May 20224209
Jun 202270017
Jul 20221604
Aug 20223406
Sep 20223806
Oct 20223202
Nov 20226007
Dec 20223406
Jan 20234607
Feb 20238208
Mar 202374010
Apr 202366016
May 20237205
Jun 20233004
Jul 202372010
Aug 20234604
Sep 20233804
Oct 20235407
Nov 2023100010
Dec 20233801
Jan 20244001
Feb 2024120011
Mar 2024100043
Apr 20249008
May 20246408
Jun 20246306
Jul 20246605
Aug 20246105
Sep 20244405
Oct 20249409
Nov 202464010
Dec 202450010
Jan 202530012
Feb 20251208
Mar 20250012
Apr 20250010
May 2025007
Jun 2025208
Total28080579